| Literature DB >> 30027598 |
Rebecca Jones1, Harry W I Putnam1, Heiko Philippin2,3, Charles Cleland4, David H Steel5,6, William K Gray7, Joanna E Klaptocz7, Bernadetha Swai8, Richard W Walker7,9.
Abstract
By 2030, sub-Saharan Africa is forecast to see the steepest rise in the number of people with hypertension of any world region. Hypertensive retinopathy is known to be a common complication of hypertension in developed countries and some studies suggest it is associated with the presence of other hypertension-related end-organ damage (EOD) such as stroke and cardiovascular disease. In Tanzania hypertension is relatively more common than in other parts of sub-Saharan Africa, especially in the older population; however, the prevalence of hypertensive retinopathy and its association with EOD remain unknown. The authors conducted a cross-sectional study of elderly, community-dwelling, rural Tanzanians to determine the prevalence of hypertensive retinopathy and its association with hypertension and other forms of EOD. Hypertensive retinopathy was diagnosed based on retinal imaging. In a cohort of 61 patients with gradable images, the authors found the overall prevalence of hypertensive retinopathy to be 64% (n = 39), which was strongly associated with hypertension (X2 [1] = 4.207, P = .004), with a significant trend towards more severe retinopathy with more severe hypertension (r = .377, P = .003). The authors did not find hypertensive retinopathy to be associated with other forms of EOD. Hypertensive retinopathy is highly prevalent in this population and is associated in most but not all cases with hypertension. These findings do not suggest that it could be used as a screening tool for EOD, but it is important to identify and educate patients with retinopathy about possible complications of the condition. ©2018 Wiley Periodicals, Inc.Entities:
Keywords: Tanzania; end-organ damage; hypertension; low- and middle-income countries; retinal imaging; retinopathy; sub-Saharan Africa
Mesh:
Year: 2018 PMID: 30027598 PMCID: PMC8031222 DOI: 10.1111/jch.13352
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738